Global Mucormycosis Market Research Report 2023

Report ID: 1988678 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Diagnosis
        1.2.1 Global Mucormycosis Market Size Growth Rate by Diagnosis: 2017 VS 2021 VS 2028
        1.2.2 Computed Tomography (CT)
        1.2.3 Magnetic resonance imaging (MRI)
        1.2.4 Tissue Biopsy
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Mucormycosis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinics
        1.3.3 Medical Institutes
        1.3.4 Research Organization
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Mucormycosis Market Perspective (2017-2028)
    2.2 Mucormycosis Growth Trends by Region
        2.2.1 Mucormycosis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Mucormycosis Historic Market Size by Region (2017-2022)
        2.2.3 Mucormycosis Forecasted Market Size by Region (2023-2028)
    2.3 Mucormycosis Market Dynamics
        2.3.1 Mucormycosis Industry Trends
        2.3.2 Mucormycosis Market Drivers
        2.3.3 Mucormycosis Market Challenges
        2.3.4 Mucormycosis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Mucormycosis Players by Revenue
        3.1.1 Global Top Mucormycosis Players by Revenue (2017-2022)
        3.1.2 Global Mucormycosis Revenue Market Share by Players (2017-2022)
    3.2 Global Mucormycosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Mucormycosis Revenue
    3.4 Global Mucormycosis Market Concentration Ratio
        3.4.1 Global Mucormycosis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mucormycosis Revenue in 2021
    3.5 Mucormycosis Key Players Head office and Area Served
    3.6 Key Players Mucormycosis Product Solution and Service
    3.7 Date of Enter into Mucormycosis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Mucormycosis Breakdown Data by Diagnosis
    4.1 Global Mucormycosis Historic Market Size by Diagnosis (2017-2022)
    4.2 Global Mucormycosis Forecasted Market Size by Diagnosis (2023-2028)
5 Mucormycosis Breakdown Data by Application
    5.1 Global Mucormycosis Historic Market Size by Application (2017-2022)
    5.2 Global Mucormycosis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Mucormycosis Market Size (2017-2028)
    6.2 North America Mucormycosis Market Size by Country (2017-2022)
    6.3 North America Mucormycosis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Mucormycosis Market Size (2017-2028)
    7.2 Europe Mucormycosis Market Size by Country (2017-2022)
    7.3 Europe Mucormycosis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Mucormycosis Market Size (2017-2028)
    8.2 Asia-Pacific Mucormycosis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Mucormycosis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Mucormycosis Market Size (2017-2028)
    9.2 Latin America Mucormycosis Market Size by Country (2017-2022)
    9.3 Latin America Mucormycosis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Mucormycosis Market Size (2017-2028)
    10.2 Middle East & Africa Mucormycosis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Mucormycosis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Mucormycosis Introduction
        11.1.4 Abbott Laboratories Revenue in Mucormycosis Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Biocon
        11.2.1 Biocon Company Detail
        11.2.2 Biocon Business Overview
        11.2.3 Biocon Mucormycosis Introduction
        11.2.4 Biocon Revenue in Mucormycosis Business (2017-2022)
        11.2.5 Biocon Recent Development
    11.3 Cadila Pharmaceuticals
        11.3.1 Cadila Pharmaceuticals Company Detail
        11.3.2 Cadila Pharmaceuticals Business Overview
        11.3.3 Cadila Pharmaceuticals Mucormycosis Introduction
        11.3.4 Cadila Pharmaceuticals Revenue in Mucormycosis Business (2017-2022)
        11.3.5 Cadila Pharmaceuticals Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Mucormycosis Introduction
        11.4.4 Novartis Revenue in Mucormycosis Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Mucormycosis Introduction
        11.5.4 Merck Revenue in Mucormycosis Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Mucormycosis Introduction
        11.6.4 Roche Revenue in Mucormycosis Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 Bristol Myers Squibb
        11.7.1 Bristol Myers Squibb Company Detail
        11.7.2 Bristol Myers Squibb Business Overview
        11.7.3 Bristol Myers Squibb Mucormycosis Introduction
        11.7.4 Bristol Myers Squibb Revenue in Mucormycosis Business (2017-2022)
        11.7.5 Bristol Myers Squibb Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Mucormycosis Introduction
        11.8.4 Pfizer Revenue in Mucormycosis Business (2017-2022)
        11.8.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Mucormycosis Market Size Growth Rate by Diagnosis (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Computed Tomography (CT)
    Table 3. Key Players of Magnetic resonance imaging (MRI)
    Table 4. Key Players of Tissue Biopsy
    Table 5. Key Players of Others
    Table 6. Global Mucormycosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Mucormycosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Mucormycosis Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Mucormycosis Market Share by Region (2017-2022)
    Table 10. Global Mucormycosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Mucormycosis Market Share by Region (2023-2028)
    Table 12. Mucormycosis Market Trends
    Table 13. Mucormycosis Market Drivers
    Table 14. Mucormycosis Market Challenges
    Table 15. Mucormycosis Market Restraints
    Table 16. Global Mucormycosis Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Mucormycosis Market Share by Players (2017-2022)
    Table 18. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucormycosis as of 2021)
    Table 19. Ranking of Global Top Mucormycosis Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Mucormycosis Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Mucormycosis Product Solution and Service
    Table 23. Date of Enter into Mucormycosis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Mucormycosis Market Size by Diagnosis (2017-2022) & (US$ Million)
    Table 26. Global Mucormycosis Revenue Market Share by Diagnosis (2017-2022)
    Table 27. Global Mucormycosis Forecasted Market Size by Diagnosis (2023-2028) & (US$ Million)
    Table 28. Global Mucormycosis Revenue Market Share by Diagnosis (2023-2028)
    Table 29. Global Mucormycosis Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Mucormycosis Revenue Market Share by Application (2017-2022)
    Table 31. Global Mucormycosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Mucormycosis Revenue Market Share by Application (2023-2028)
    Table 33. North America Mucormycosis Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Mucormycosis Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Mucormycosis Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Mucormycosis Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Mucormycosis Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Mucormycosis Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Mucormycosis Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Mucormycosis Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Mucormycosis Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Mucormycosis Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Abbott Laboratories Company Detail
    Table 44. Abbott Laboratories Business Overview
    Table 45. Abbott Laboratories Mucormycosis Product
    Table 46. Abbott Laboratories Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 47. Abbott Laboratories Recent Development
    Table 48. Biocon Company Detail
    Table 49. Biocon Business Overview
    Table 50. Biocon Mucormycosis Product
    Table 51. Biocon Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 52. Biocon Recent Development
    Table 53. Cadila Pharmaceuticals Company Detail
    Table 54. Cadila Pharmaceuticals Business Overview
    Table 55. Cadila Pharmaceuticals Mucormycosis Product
    Table 56. Cadila Pharmaceuticals Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 57. Cadila Pharmaceuticals Recent Development
    Table 58. Novartis Company Detail
    Table 59. Novartis Business Overview
    Table 60. Novartis Mucormycosis Product
    Table 61. Novartis Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 62. Novartis Recent Development
    Table 63. Merck Company Detail
    Table 64. Merck Business Overview
    Table 65. Merck Mucormycosis Product
    Table 66. Merck Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 67. Merck Recent Development
    Table 68. Roche Company Detail
    Table 69. Roche Business Overview
    Table 70. Roche Mucormycosis Product
    Table 71. Roche Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 72. Roche Recent Development
    Table 73. Bristol Myers Squibb Company Detail
    Table 74. Bristol Myers Squibb Business Overview
    Table 75. Bristol Myers Squibb Mucormycosis Product
    Table 76. Bristol Myers Squibb Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 77. Bristol Myers Squibb Recent Development
    Table 78. Pfizer Company Detail
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Mucormycosis Product
    Table 81. Pfizer Revenue in Mucormycosis Business (2017-2022) & (US$ Million)
    Table 82. Pfizer Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mucormycosis Market Share by Diagnosis: 2021 VS 2028
    Figure 2. Computed Tomography (CT) Features
    Figure 3. Magnetic resonance imaging (MRI) Features
    Figure 4. Tissue Biopsy Features
    Figure 5. Others Features
    Figure 6. Global Mucormycosis Market Share by Application in 2021 & 2028
    Figure 7. Hospitals & Clinics Case Studies
    Figure 8. Medical Institutes Case Studies
    Figure 9. Research Organization Case Studies
    Figure 10. Others Case Studies
    Figure 11. Mucormycosis Report Years Considered
    Figure 12. Global Mucormycosis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Mucormycosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Mucormycosis Market Share by Region: 2021 VS 2028
    Figure 15. Global Mucormycosis Market Share by Players in 2021
    Figure 16. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucormycosis as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Mucormycosis Revenue in 2021
    Figure 18. North America Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Mucormycosis Market Share by Country (2017-2028)
    Figure 20. United States Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Mucormycosis Market Share by Country (2017-2028)
    Figure 24. Germany Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Mucormycosis Market Share by Region (2017-2028)
    Figure 32. China Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Mucormycosis Market Share by Country (2017-2028)
    Figure 40. Mexico Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Mucormycosis Market Share by Country (2017-2028)
    Figure 44. Turkey Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Mucormycosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Abbott Laboratories Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 47. Biocon Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 48. Cadila Pharmaceuticals Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 50. Merck Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 51. Roche Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 52. Bristol Myers Squibb Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in Mucormycosis Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
Frequently Asked Questions
Mucormycosis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mucormycosis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mucormycosis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Multimedia Chipset

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More